Structure, mechanism, and regulation of polycomb-repressive complex 2

Area of Science:

• Epigenetics
• Molecular Biology
• Structural Biology

Background:

• Polycomb repressive complex 2 (PRC2) is crucial for epigenetic gene silencing via H3K27 methylation.
• PRC2 dysregulation is linked to various cancers, highlighting its role in disease.
• Understanding PRC2 is vital for developing targeted cancer therapies.

Purpose of the Study:

• To review recent advances in understanding PRC2 structure and function.
• To elucidate the catalytic mechanism, substrate specificity, and regulation of PRC2.
• To discuss PRC2 inhibition strategies for cancer treatment.

Main Methods:

• Analysis of recent crystallographic studies of the PRC2 core complex.
• Integration of biochemical and genetic data on PRC2 activity.
• Review of preclinical and clinical data on PRC2 inhibitors.

Main Results:

• Elucidation of the first crystal structures of the PRC2 core complex.
• Insights into the allosteric regulation and substrate recognition of PRC2.
• Identification of small molecule inhibitors targeting PRC2, currently in clinical trials.

Conclusions:

• PRC2 structure-function studies provide a foundation for rational drug design.
• Targeting PRC2 offers a promising therapeutic strategy for various cancers.
• Further research is needed to fully understand PRC2's role and harness its therapeutic potential.